122 related articles for article (PubMed ID: 2906191)
1. Unusual mitochondrial reaction in psoriatic keratinocytes.
Klug H; Schulze P
Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 56(3):201-3. PubMed ID: 2906191
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial ring-phenomenon of keratinocytes in psoriasis vulgaris after dithranol therapy.
Klug H; Schulze P
J Cutan Pathol; 1987 Aug; 14(4):212-6. PubMed ID: 2442211
[No Abstract] [Full Text] [Related]
3. Electron microscopy of the effects of dithranol on healthy and on psoriatic skin.
Kanerva L
Am J Dermatopathol; 1990 Feb; 12(1):51-62. PubMed ID: 2316816
[TBL] [Abstract][Full Text] [Related]
4. Alteration of the expression of Bcl-2, Bcl-x, Bax, Fas, and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy.
Yamamoto T; Nishioka K
Skin Pharmacol Appl Skin Physiol; 2003; 16(1):50-8. PubMed ID: 12566829
[TBL] [Abstract][Full Text] [Related]
5. Anthralin modulates the expression pattern of cytokeratins and antimicrobial peptides by psoriatic keratinocytes.
Holstein J; Fehrenbacher B; Brück J; Müller-Hermelink E; Schäfer I; Carevic M; Schittek B; Schaller M; Ghoreschi K; Eberle FC
J Dermatol Sci; 2017 Sep; 87(3):236-245. PubMed ID: 28673488
[TBL] [Abstract][Full Text] [Related]
6. Mast cell alterations in chronic psoriasis vulgaris: response to low-strength anthralin treatment. A transmission electron microscopic study.
Brody I
Ups J Med Sci; 1986; 91(1):1-16. PubMed ID: 3716018
[TBL] [Abstract][Full Text] [Related]
7. The response of uninvolved skin of patients with psoriasis to single and repeated applications of dithranol cream: an immunohistochemical assessment.
Swinkels OQ; Prins M; van Vlijmen-Willems IM; Gerritsen MJ; van der Valk PG; van de Kerkhof PC
Skin Pharmacol Appl Skin Physiol; 2002; 15(6):385-92. PubMed ID: 12476012
[TBL] [Abstract][Full Text] [Related]
8. The effect of fumaric acid esters and dithranol on acanthosis and hyperproliferation in psoriasis vulgaris.
Bacharaçh-Buhles M; Röchling A; el Gammal S; Altmeyer P
Acta Derm Venereol; 1996 May; 76(3):190-3. PubMed ID: 8800297
[TBL] [Abstract][Full Text] [Related]
9. Skin polyamine levels in psoriasis: the effect of dithranol therapy.
Bohlen P; Grove J; Beya MF; Koch-Weser J; Henry MH; Grosshans E
Eur J Clin Invest; 1978 Aug; 8(4):215-8. PubMed ID: 100325
[TBL] [Abstract][Full Text] [Related]
10. [Dynamics of regression of psoriatic changes under the effect of cygnoline in the light of ultrastructural studies. II. Psoriatic changes after treatment with cygnoline].
Szczeklik-Franek A; Rubisz-Brzezińska JA; Grzybek H
Patol Pol; 1979; 30(1):43-8. PubMed ID: 503597
[No Abstract] [Full Text] [Related]
11. The influence of a topical corticosteroid on short-contact high-dose dithranol therapy.
Swinkels OQ; Prins M; Tosserams EF; Gerritsen MJ; Van Der Valk PG; Van De Kerkhof PC
Br J Dermatol; 2001 Jul; 145(1):63-9. PubMed ID: 11453908
[TBL] [Abstract][Full Text] [Related]
12. Superimposed linear psoriasis: differential therapeutic response of linear and nonlinear lesions.
Seitz CS; Garbaraviciene J; Bröcker EB; Hamm H
Clin Exp Dermatol; 2009 Jul; 34(5):e177-9. PubMed ID: 19094135
[TBL] [Abstract][Full Text] [Related]
13. Epidermal activity of NAD-dependent isocitrate dehydrogenase in psoriasis during treatment with dithranol.
Hammar H
J Invest Dermatol; 1975 Sep; 65(3):315-9. PubMed ID: 169306
[TBL] [Abstract][Full Text] [Related]
14. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model.
Sathe P; Saka R; Kommineni N; Raza K; Khan W
Drug Dev Ind Pharm; 2019 May; 45(5):826-838. PubMed ID: 30764674
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence remission spectroscopy of psoriatic lesions and the effect of topical anthralin therapy.
Wollina U; Schmidt WD; Koch A; Scheibe A; Erfurth F; Fassler D
J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1409-13. PubMed ID: 19508501
[TBL] [Abstract][Full Text] [Related]
16. Dithranol: a review of the mechanism of action in the treatment of psoriasis vulgaris.
Kemény L; Ruzicka T; Braun-Falco O
Skin Pharmacol; 1990; 3(1):1-20. PubMed ID: 2202336
[TBL] [Abstract][Full Text] [Related]
17. Measurement of plaque thickness and evaporative water loss in psoriasis with PUVA and dithranol treatment.
Rogers S
Clin Exp Dermatol; 1993 Jan; 18(1):21-4. PubMed ID: 8440047
[TBL] [Abstract][Full Text] [Related]
18. The effect of steroid and dithranol therapy on cyclic nucleotides in psoriatic epidermis.
Saihan EM; Albano J; Burton JL
Br J Dermatol; 1980 May; 102(5):565-9. PubMed ID: 6248098
[TBL] [Abstract][Full Text] [Related]
19. [Effect of dithranol therapy on membrane, basement membrane and nuclear markers in psoriasis lesions].
Wollina U; Schlesier F; Schaarschmidt H; Knopf B; Hipler C; Henkel U; Roth H; Bartá U
Z Hautkr; 1987 Feb; 62(4):313-8. PubMed ID: 3554801
[TBL] [Abstract][Full Text] [Related]
20. Epidermal differentiation characteristics of the psoriatic plaque during short contact treatment with dithranol cream.
van der Vleuten CJ; de Jong EM; van de Kerkhof PC
Clin Exp Dermatol; 1996 Nov; 21(6):409-14. PubMed ID: 9167334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
